Trial intelligence / Profile preview

Phase II study of HW231019 tablets for postoperative analgesia after abdominal surgery

CTR20254291Phase 2Completed

Sponsor
Yichang Humanwell Pharmaceutical Co., Ltd.
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of HW231019 in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Dec 2025; status: completed.

02

Drugs

HW231019
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20254291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20254291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call